secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-04-08T23:59:59+00:00
Accession:  0000950170-24-042424
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix raises up to $4M in registered direct offering with DB Capital Partners
--------------------------------------------------------------------------------

- Initial tranche of $1.0M at $0.75 per ADS ($0.375 per ordinary share) closing by April 11.
- Optional second tranche of up to ~$3M at same price, exercisable until April 17.
- Net proceeds to support commercial sales activity and ongoing Formal Sale Process.
- Purchaser DB Capital Partners Healthcare will hold ~2.18% of shares after initial closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024042424/0000950170-24-042424-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024042424/rnlx-20240408.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-042424

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer